Share This Article:

Influence on proliferation and inducing capacity of bone mesenchymal stem cells during myocardial differentiation and construction of engineered myocardium-like tissue in vitro

Abstract Full-Text HTML XML Download Download as PDF (Size:1108KB) PP. 90-98
DOI: 10.4236/scd.2013.32014    3,244 Downloads   5,183 Views  

ABSTRACT

The study is to investigate BMSCs ability to differentiate cardiomyocytes, especially discussed cell generations and 5-Aaz concentration influence on BMSCs capability of proliferation and differentiation into cardiomyocytes during constructing the engineered myocardium-like tissue in vitro. The results have demonstrated that the different concentration of 5-Aza has the influence on proliferation rate of different generations of BMSCs, the second generation BMSCs was superior to the sixth, and tenth generation in proliferation capacity after being induced, and 5-Aza had some influence on proliferation capacity. Rat BMSCs could be differentiated into cardiomyocytes-like cells, which have a good biocompatibility with acellular bovine pericardium, and myocardium-like tissue could be engineered with BMSCs and acellular bovine pericardium in vitro. In conclusion, BMSCs could be induced and differentiated into cardiomyocytes-like cells in vitro. Different generations and different 5-Aza density have influence on the rate of increase of BMSCs, and the engineered myocardium-like tissue could be constructed with BMSCs and acellular bovine pericardium in vitro.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Xing, W. , Tian, L. , Zhang, J. , Wang, N. , Chen, P. and Ma, J. (2013) Influence on proliferation and inducing capacity of bone mesenchymal stem cells during myocardial differentiation and construction of engineered myocardium-like tissue in vitro. Stem Cell Discovery, 3, 90-98. doi: 10.4236/scd.2013.32014.

References

[1] Ding, W.-X. (2000) The review and prospect of pediatric heart surgery in China. Chinese Journal of Pediatric Surgery, 21, 266.
[2] Sakai, T., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.T., Jia, Z.Q. and Yau, T.M. (2001) The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. The Journal of Thoracic and Cardiovascular Surgery, 121, 932-942. doi:10.1067/mtc.2001.113600
[3] Mirsadraee, S., Wilcox, H.E., Watterson, K.G., Kearney, J.N., Hunt, J., Fisher, J. and Ingham, E. (2007) Biocompatibility of acellular human pericardium. Journal of Surgical Research, 143, 407-414. doi:10.1016/j.jss.2007.01.026
[4] Young, H.E., Mancini, M.L., Wright, R.P., Smith, J.C., Black Jr., A.C., Reagan, C.R. and Lucas, P.A. (1995) Mesenchymal stem cells reside within the connective tissues of many organs. Developmental Dynamics, 202, 137-144. doi:10.1002/aja.1002020205
[5] Prockop, D.J. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276, 71-74. doi:10.1126/science.276.5309.71
[6] Kern, S., Eichler, H., Stoeve, J., Klüter, H. and Bieback, K. (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294-1301. doi:10.1634/stemcells.2005-0342
[7] Wakitami, S., Saito, T. and Caplan, A.I. (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 18, 1417-1426. doi:10.1002/mus.880181212
[8] Tomita, S., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.J., Sakai, T. and Jia, Z.Q. (1999) Autologus transplantation of bone marrow cells improves damaged heart function. Circulation, 100, 247-256.
[9] Xu, W., Zhang, X., Qian, H., Zhu, W., Sun, X., Hu, J., Zhou, H. and Chen, Y. (2004) Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Experimental Biology and Medicine, 229, 623-631.
[10] Ishii, O., Shin, M., Sueda, T. and Vacanti, J.P. (2005) In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. The Journal of Thoracic and Cardiovascular Surgery, 130, 1358-1363. doi:10.1016/j.jtcvs.2005.05.048
[11] Guo, X.M., Zhao, Y.S., Chang, H.X., Wang, C.Y., E, L.L., Zhang, X.A., Duan, C.M., Dong, L.Z., Jiang, H., Li, J., Song, Y. and Yang, X.J. (2006) Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation, 113, 2229-2237. doi:10.1161/CIRCULATIONAHA.105.583039
[12] Capi, O. and Gepstein, L. (2006) Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. Journal of Controlled Release, 116, 211-218. doi:10.1016/j. jconrel.2006.06.027
[13] Cheng, M., Park, H., Engelmayr, G.C., Moretti, M. and Freed, L.E. (2007) Effects of regulatory factors on engineered cardiac tissue in vitro. Tissue Engineering, 13, 2709-2719. doi:10.1089/ ten.2006.0414
[14] Leor, J., Aboulafia-Etzion, S., Dar, A., Shapiro, L., Barbash, I.M., Battler, A., Granot, Y. and Cohen, S. (2000) Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium. Circulation, 102, 56-61.
[15] Ishii, O., Shin, M., Sueda, T. and Vacanti, J.P. (2005) In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. The Journal of Thoracic and Cardiovascular Surgery, 130, 1358-1363. doi:10.1016/j.jtcvs.2005.05.048
[16] Courtman, D.W., Pereira, C.A., Kashef, V., McComb, D., Lee, J.M. and Wilson, G.J. (1994) Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. Journal of Biomedical Materials Research, 28, 655-666. doi:10.1002/jbm.820280602
[17] Mirensky, T.L. and Breuer, C.K. (2008) The development of tissue-engineered grafts for reconstructive cardiotho racic surgical applications. Pediatric Research, 63, 559-568. doi:10.1203/01.pdr.0000305938.92695.b9
[18] Ge, D., Liu, X., Li, L., Wu, J., Tu, Q., Shi, Y. and Chen, H. (2009) Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells. Biochemical and Biophysical Research Communications, 381, 317-321. doi:10.1016/j.bbrc.2009.01.173
[19] Yuasa, S. and Fukuda, K. (2008) Cardiac regenerative medicine. Circulation Journal, 72, 49-55. doi:10.1253/circj.CJ-08-0378
[20] Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. and Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147. doi:10.1126/science.284.5411.143
[21] Psaltis, P.J., Zannettino, A.C., Worthley, S.G. and Gronthos, S. (2008) Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells, 26, 2201-2210. doi:10.1634/stemcells.2008-0428
[22] Sekiya, I., Larson, B.L., Smith, J.R., Pochampally, R., Cui, J.G. and Prockop, D.J. (2002) Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells, 20, 530-541. doi:10.1634/stemcells.20-6-530
[23] Qian, H.Y. (2007) Experimental study of cardiomyocyte differentiation from porcine bone marrow mesenchymal stem cell in vitro and optimized transplantation to treat acute myocardial infarction in vivo. Ph.D. Thesis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
[24] Yoon, J., Shim, W.J., Ro, Y.M. and Lim, D.S. (2005) Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. Annals of Hematology, 84, 715-721. doi:10.1007/s00277-005-1068-7
[25] Akhyari, P., Kamiya, H., Haverich, A., Karck, M. and Lichtenberg, A. (2008) Myocardial tissue engineering: The extracellular matrix. European Journal Cardio-Thoracic Surgery, 34, 229-241. doi:10.1016/j.ejcts.2008.03.062
[26] Kanematsu, A., Yamamoto, S., Ozeki, M., Noguchi, T., Kanatani, I., Ogawa, O. and Tabata, Y. (2004) Collagenous matrices as release carriers of exogenous growth factors. Biomaterials, 25, 4513-4320. doi:10.1016/j.biomaterials.2003.11.035
[27] Chang, Y., Tsai, C.C., Liang, H.C. and Sung, H.W. (2002) In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials, 23, 2447-2457. doi:10.1016/S0142-9612(01)00379-9
[28] Wang, S. and Li, W.-B. (2009) Current situation and prospect in the study of acellular tissue engineering heart valve. China Medical Device Information, 15, 13-21.
[29] Salacinski, H. J., Tiwari, A., Hamilton, G. and Seifalian, A.M. (2001) Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment. Medical & Biological Engineering & Computing, 39, 609-618. doi:10.1007/BF02345431

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.